Prognostic significance of galectin‐3 expression in patients with resected NSCLC treated with platinum‐based adjuvant chemotherapy

BACKGROUND: Galectin‐3 (GAL3), a protein encoded by the LGALS3 gene, plays diverse roles in cancer initiation, progression, and drug resistance. Accordingly, high GAL3 expression in tumor cells is associated with poor prognosis in non‐small cell lung cancer (NSCLC). However, the prognostic impact of...

Descripción completa

Detalles Bibliográficos
Autores principales: Kusuhara, Seiichiro, Igawa, Satoshi, Ichinoe, Masaaki, Nagashio, Ryo, Kuchitsu, Yuki, Hiyoshi, Yasuhiro, Shiomi, Kazu, Murakumo, Yoshiki, Saegusa, Makoto, Satoh, Yukitoshi, Sato, Yuichi, Naoki, Katsuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107024/
https://www.ncbi.nlm.nih.gov/pubmed/33793071
http://dx.doi.org/10.1111/1759-7714.13945

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107024/
https://www.ncbi.nlm.nih.gov/pubmed/33793071
http://dx.doi.org/10.1111/1759-7714.13945

Ejemplares similares